Patrícia Bacalhau
About
Patrícia Bacalhau has a background in supramolecular chemistry and biochemical mechanisms of neurodegenerative diseases, holds a degree in Biochemistry from the University of Algarve (Portugal), an MSc degree in Chemistry Teaching and a Ph.D. in Biochemistry from the University of Évora. Her training in molecular synthesis started in 1999 as a student at ITQB, where Patrícia developed lanthanide coordinated crown azamacrocycles (radiolabelled with 153Sm) for therapeutic use in bone cancer (Portugal). During her Ph.D research under the supervision of Prof. Anthony Burke and Prof. Maria do Rosário Martins (Universidade de Évora, Portugal), Patrícia engaged the study of the biochemical mechanisms involved in Alzheimer’s and Parkinson’s diseases. Her main results involved the discovery of a lead compound with therapeutic benefits for AD. Her Ph.D. was successfully completed in 4 years. During this time, Patrícia published several peer reviewed papers, a patent and her investigation also produced numerous presentations in international congresses. Recently, Patrícia published a paper with the results of the toxicological and pharmacological studies on the lead compound, and has another 2 manuscripts in the pipeline. For the past 16 years, Patrícia has been a Physics and Chemistry high school teacher and aims to fully focus on her researcher career.
Research interests
Top-100
Fields of science
|
1
2
3
|
|
|
Organic Chemistry
|
Organic Chemistry, 3, 50%
Organic Chemistry
3 publications, 50%
|
|
Drug Discovery
|
Drug Discovery, 3, 50%
Drug Discovery
3 publications, 50%
|
|
Biochemistry
|
Biochemistry, 3, 50%
Biochemistry
3 publications, 50%
|
|
Molecular Biology
|
Molecular Biology, 3, 50%
Molecular Biology
3 publications, 50%
|
|
General Chemistry
|
General Chemistry, 2, 33.33%
General Chemistry
2 publications, 33.33%
|
|
Pharmaceutical Science
|
Pharmaceutical Science, 1, 16.67%
Pharmaceutical Science
1 publication, 16.67%
|
|
Clinical Biochemistry
|
Clinical Biochemistry, 1, 16.67%
Clinical Biochemistry
1 publication, 16.67%
|
|
Molecular Medicine
|
Molecular Medicine, 1, 16.67%
Molecular Medicine
1 publication, 16.67%
|
|
General Chemical Engineering
|
General Chemical Engineering, 1, 16.67%
General Chemical Engineering
1 publication, 16.67%
|
|
Neurology
|
Neurology, 1, 16.67%
Neurology
1 publication, 16.67%
|
|
Neurology (clinical)
|
Neurology (clinical), 1, 16.67%
Neurology (clinical)
1 publication, 16.67%
|
|
1
2
3
|
Journals
|
1
2
|
|
|
Bioorganic Chemistry
2 publications, 33.33%
|
|
|
Bioorganic and Medicinal Chemistry
1 publication, 16.67%
|
|
|
RSC Advances
1 publication, 16.67%
|
|
|
ChemistrySelect
1 publication, 16.67%
|
|
|
Neurodegenerative Diseases
1 publication, 16.67%
|
|
|
1
2
|
Citing journals
Publishers
|
1
2
3
|
|
|
Elsevier
3 publications, 50%
|
|
|
Wiley
1 publication, 16.67%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 16.67%
|
|
|
S. Karger AG
1 publication, 16.67%
|
|
|
1
2
3
|
Organizations from articles
|
1
2
3
4
5
|
|
|
University of Évora
5 publications, 83.33%
|
|
|
Organization not defined
|
Organization not defined, 1, 16.67%
Organization not defined
1 publication, 16.67%
|
|
University of Lisbon
1 publication, 16.67%
|
|
|
Universidad de Sevilla
1 publication, 16.67%
|
|
|
1
2
3
4
5
|
Countries from articles
|
1
2
3
4
5
|
|
|
Portugal
|
Portugal, 5, 83.33%
Portugal
5 publications, 83.33%
|
|
Country not defined
|
Country not defined, 3, 50%
Country not defined
3 publications, 50%
|
|
Spain
|
Spain, 1, 16.67%
Spain
1 publication, 16.67%
|
|
1
2
3
4
5
|
Citing organizations
Citing countries
- We do not take into account publications without a DOI.
- Statistics recalculated daily.